首页> 外文期刊>The journal of obstetrics and gynaecology research >Recombinant activated factor VII in the management of acute fatty liver of pregnancy: A case report
【24h】

Recombinant activated factor VII in the management of acute fatty liver of pregnancy: A case report

机译:重组激活因子VII在妊娠急性脂肪肝治疗中的一例报道

获取原文
获取原文并翻译 | 示例
           

摘要

A 20-year-old woman, primigravida at 36(+4) weeks' gestation presented with malaise, vomiting for 1 week, yellowish discoloration of the eyes for 3 days and loss of fetal movements. A clinical diagnosis of acute fatty liver with intrauterine fetal demise was made. Labor was induced with prostaglandin E2 gel and delivered vaginally. The post-partum period was complicated by atonic post-partum hemorrhage, an episode of seizure, recurrent hypoglycemic attack, hypokalemia and continuing coagulopathy. Supportive management in the intensive care unit using blood and blood products and injection recombinant activated factor VIIa to arrest the bleeding resulted in a successful outcome.
机译:一名20岁女性,在妊娠36(+4)周时初产妇出现不适,呕吐1周,眼部变黄3天,并且胎动减弱。进行了子宫内胎儿死亡的急性脂肪肝的临床诊断。前列腺素E2凝胶可引产并经阴道分娩。产后时期并发有无瓣膜的产后出血,癫痫发作,反复降血糖发作,低钾血症和持续性凝血病。重症监护病房的支持性治疗使用血液和血液制品以及注射重组活化的因子VIIa来止血,取得了成功的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号